Last week, the Wall Street Journal reported that manufacturer Daiichi Sankyo agreed to settle a lawsuit for $39 million after it was accused of paying kickbacks to physicians to prescribe several of its drugs.
The newspaper reported that the lawsuit was sparked by claims filed under whistleblower provisions of the False Claims Act by a former sales rep. As part of the settlement, the manufacturer also agreed to a corporate integrity agreement, stipulating that it “must implement compliance programs to prevent such illegal practices from occurring in the future.”
Daiichi Sankyo was accused of paying kickbacks in the form of speaking events and meals. The U.S. Department of Justice claimed that some of the doctors’ speaking engagements were nothing but shams, that some physicians “spoke only to his or her own office staff,” and that some audiences only included the doctors’ spouses.
Daiichi Sankyo was accused of encouraging doctors to prescribe Welchol, a cholesterol-lowering medication, and Benicar, Azor, and Tribenzor, which are high blood pressure pills, according to the Journal.
As we have reported previously in our blog, Benicar and other drugs with antihypertensive agents have been linked to complications, including severe intestinal sprue-like enteropathy, a condition similar to celiac disease. This makes the fact that Daiichi Sankyo was accused of promoting kickbacks alarming.
For more information about Benicar, Azor, and Tribenzor, speak to the drug injury attorneys at ZK Law. We are currently investigating these drugs. Remember, our attorneys hold negligent drug manufacturers liable for injuries sustained by victims.
To read about the settlement, you can click on the source link below or view the agreement by clicking here.
Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers
Source: http://blogs.wsj.com/pharmalot/2015/01/12/daiichi-sankyo-pays-39m-to-settle-kickback-charges/
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.